Jeffrey Schelling, MD, Case Western Reserve University, 2023 Harrington Scholar-Innovator, is pioneering a new treatment for diabetic kidney disease by targeting the fatty acid transport protein-2 (FATP2). His research aims to slow disease progression and improve kidney function, offering new hope for patients. Harrington Discovery Institute at University Hospitals in Cleveland, Ohio aims to accelerate promising discoveries into medicines for unmet needs. Learn more: HarringtonDiscovery.org.
